NEW YORK (AP) — Researchers on Tuesday reported another record one-year decline in the U.S. cancer death rate, a drop they attribute to success against lung cancer.

A U.S. health panel wants to widen the number of Americans offered yearly scans for lung cancer by opening the screening to less-heavy smokers.

Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear.

PHOENIX (AP) — A 79-year-old man with lung cancer became the second inmate in Arizona’s prisons to die from the coronavirus.

The prisoner known as Sittingdown, who didn’t have a first name...

MONTGOMERY, Ala. (AP) — Medical scans show Alabama Gov. Kay Ivey is free of the lung cancer she was diagnosed with last year, her office said Wednesday.

NEW YORK (AP) — Researchers on Wednesday reported the largest-ever one-year decline in the U.S. cancer death rate, a drop they credited to advances in lung-tumor treatments.

MONTEVIDEO, Uruguay (AP) — Uruguayan President Tabaré Vázquez announced Tuesday that he has cancer and will have a more complete diagnosis in coming days.

SAN DIEGO (AP) — California has a 28 percent lower lung cancer death rate than the rest of the country thanks to statewide policies against tobacco, a study concluded.

As far back as the 1980s the state highlighted the link between smoking and cancer and introduced the nation's first tobacco control program.

Those efforts resulted in fewer people starting smoking and more people quitting, researchers at the University of California, San Diego announced Wednesday.

Lung cancer screening has proved to be stunningly unpopular. Five years after government and private insurers started paying for it, less than 2 percent of eligible current and former smokers have sought the free scans, researchers report.

The study didn't explore why, but experts say possible explanations include worries about false alarms and follow-up tests, a doctor visit to get the scans covered, fear and denial of the consequences of smoking and little knowledge that screening exists.

CHICAGO (AP) — For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers.

NEW YORK (AP) — Veteran broadcaster Larry King says he battled lung cancer this summer but appears to have the disease at bay.

The former CNN host, who is 83, told Us Weekly that a spot on his lung was noticed this summer during a routine check-up. He said he had surgery in July. The tumor was malignant but King said it was found at such an early stage that his doctor told him he was lucky.

For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, the focus for many years.

People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more study because the heart experiment wasn't intended to test that.

LONDON (AP) — Shares in Anglo-Swedish drugmaker AstraZeneca plunged as much as 17 percent Thursday after a new lung cancer treatment proved less successful than the company had hoped.

CHICAGO (AP) — Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Chemotherapy is notorious for making hair fall out, but the 14 patients involved were all being treated with new immunotherapy drugs that work differently and have different side effects. A Spanish study suggests that may include restoring hair pigment, at least in patients with lung cancer.

BOSTON (AP) — Researchers have taken an important step toward better lung cancer treatment by using blood tests to track genetic changes in tumors as they progress from their very earliest stages.

With experimental tests that detect bits of DNA that tumors shed into the blood, they were able to detect some recurrences of cancer up to a year before imaging scans could, giving a chance to try new therapy sooner.

AUSTIN, Texas (AP) — Six holes into his opening match, Jason Day walked off the golf course.

It was the fourth time in the last three years that he withdrew in the middle of a tournament.

Only this was different.

Physically, he never felt better. Emotionally, he was a wreck.

NEW YORK (AP) — A blockbuster cancer treatment failed in a key study as the drug's maker, Bristol-Myers Squibb, attempts to extend its usage for lung cancer patients.

Shares of the New York company plunged 16 percent Friday, its biggest one-day drop in 14 years. Shares of rival Merck & Co., which makes a rival cancer drug, spiked 10 percent to reach an 18-year high.

Bristol's drug, Opdivo, and Merck's drug Keytruda are immunotherapies, which bolster the...